These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3653223)

  • 1. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.
    Caruana M; Heber M; Brigden G; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):549-53. PubMed ID: 3653223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sustained-release Verapamil on the morning systemic arterial pressure surge during daily activity in patients with systemic hypertension.
    Rosito GA; Gebara OC; McKenna CA; Solomon HS; Muller JE; Tofler GH
    Am J Cardiol; 1997 May; 79(9):1252-5. PubMed ID: 9164897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness.
    Novo S; Alaimo G; Abrignani MG; Longo B; Muratore G; Strano A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S38-41. PubMed ID: 2475683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mild to moderate hypertension with verapamil slow-release in outpatients. Collaborative Group of the Spanish League for the Fight Against Hypertension.
    Gómez Pajuelo C; Pérez Naranjo J; Ruiz Martínez I
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S50-2. PubMed ID: 2475687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of slow-release verapamil and nitrendipine on office and 24-hour ambulatory blood pressure in hypertensive patients.
    Pannarale G; Puddu PE; Campbell SV; Collauto F; Stazi F; Reale A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S53-6. PubMed ID: 1377307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily nisoldipine in hypertension: cuff and ambulatory intra-arterial blood pressure.
    Brigden G; Heber M; Caruana M; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1989; 37(6):551-4. PubMed ID: 2612549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Savi L; Guardigli R; Mores N; Folli G
    Eur J Clin Pharmacol; 1988; 34(6):549-53. PubMed ID: 3169108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
    Frishman W; Charlap S; Kimmel B; Saltzberg S; Stroh J; Weinberg P; Monuszko E; Wiezner J; Dorsa F; Pollack S
    Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once a day verapamil in essential hypertension.
    Müller FB; Ha HR; Hotz H; Schmidlin O; Follath F; Bühler FR
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):143S-147S. PubMed ID: 3530298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording.
    Fariello R; Boni E; Corda L; Cantalamessa A; Zaninelli A; Pollavini G; Alicandri C; Muiesan G
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):27-33. PubMed ID: 2006994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.
    Fuenmayor NT; Faggin BM; Cubeddu LX
    Drugs; 1992; 44 Suppl 1():1-11. PubMed ID: 1283570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.